Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa
Loading...
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Tropical Medicine & International Health
Abstract
To investigate the current status of the availability and affordability of specific essential medicines and
diagnostics for diabetes in Africa.
Methods: Systematic review and meta-analysis. Studies conducted in Africa that reported any information on the
availability and affordability of short-acting, intermediate-acting, and premixed insulin, glibenclamide, metformin,
blood glucose, glycated haemoglobin or HbA1c, and lipid profile tests were included. Random-effect model metaanalysis
and descriptive statistics were performed to determine the pooled availability and affordability, respectively.
Results: A total of 21 studies were included. The pooled availability of each drug was as follows: short-acting insulin
33.5% (95% CI: 17.8% - 49.2%, I2=95.02%), intermediate-acting insulin 23.1% (95% CI: 6.3% - 39.9%, I2=91.6%),
premixed insulin 49.4% (95% CI: 24.9% - 73.9%, I2=90.57%), glibenclamide 55.9% (95% CI: 43.8% - 68.0%, I2=96.7%),
and metformin 47.0% (95% CI: 34.6% - 59.4, I2=97.54%). Regarding diagnostic tests, for glucometers the pooled
availability was 49.5% (95% CI: 37.9% - 61.1%, I2=97.43%), for HbA1c 24.6% (95% CI: 3.1% - 46.1%, I2=91.64), and for
lipid profile tests 35.7% (95% CI: 19.4% - 51.9%, I2=83.77%). The median (IQR) affordability in days’ wages was 7 (4.7-
7.5) for short-acting insulin, 4.4 (3.9-4.9) for intermediate-acting insulin, 7.1 (5.8-16.7) for premixed insulin, 0.7 (0.7-
0.7) for glibenclamide, and 2.1 (1.8-2.8) for metformin.
Conclusion: The availability of the five essential medicines and three diagnostic tests for diabetes in Africa is
suboptimal. The relatively high cost of insulin, HbA1c, and lipid profile tests is a significant barrier to optimal diabetes
care. Pragmatic country-specific strategies are urgently needed to address these inequities in access and cost.
Description
Keywords
Availability, Affordability, Essential medicines, Diagnostic tests, Diabetes mellitus
Citation
Kibirige, D., Olum, R., Kyazze, A. P., Bongomin, F., & Sanya, R. E. (2022). Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa. Tropical Medicine & International Health, 27(11), 942-960. doi: 10.1111/tmi.13819